Descripción del proyecto
Nueva interfaz de inteligencia artificial para ayudar a los supervivientes de cáncer
Los avances en el diagnóstico precoz y la terapia del cáncer han mejorado considerablemente las probabilidades de supervivencia, pero garantizar que estos supervivientes tengan la mejor calidad de vida posible supone un gran desafío. El proyecto financiado con fondos europeos ONCORELIEF recopila los últimos avances tecnológicos y en psicología ocupacional/servicios sanitarios, y desarrolla un sistema de inteligencia artificial (IA) centrado en el usuario para crear un asistente digital inteligente e intuitivo llamado Guardian Angel (ángel de la guarda). Además de prestar un apoyo personalizado en las actividades y tareas posteriores al tratamiento, también sugiere acciones relacionadas con el estado de salud general de los pacientes, la mejora del bienestar y una atención sanitaria activa. En última instancia, Guardian Angel ayudará a los supervivientes de cáncer a seguir implicados en un programa de bienestar que protegerá su salud durante el período posterior al tratamiento del cáncer.
Objetivo
The burden of cancer is rising globally and is estimated to have reached 18.1 million new cases and 9.6 million cancer deaths in 2018. Despite the rising cancer incidence, improvements in early detection and therapeutic treatment have improved cancer survival. As a consequence, the number of cancer survivors is increasing globally, creating the need to improve not only treatment but also wellness and follow‐up care. Cancer treatment often involves combined modalities such as surgery, chemotherapy, and radiotherapy. In the past decades, more effective and targeted therapeutic modalities and less destructive cancer treatments have been developed such as immunotherapy and drug‐targeted therapy. Even so, cancer and its treatment have important physical and psychosocial sequelae. ONCORELIEF is a 36-month action that will leverage the above 6 drivers in order to skillfully and methodologically overcome technical challenges, by introducing new approaches that will allow the utilization of big datasets in order to develop a user-centered AI System to facilitate the integration of QoL assessment instruments through the use of PROMs and PREMs in order to improve post-treatment health status, increase the wellbeing, and follow‐up care of cancer patients. This will be achieved through an intuitive smart digital assistant (Guardian Angel), able to provide personalized support in post-treatment activities and tasks, suggest actions regarding the patients' overall health-status, improved wellbeing and active health-care and ultimately maintain him/her engaged on a wellness journey that will safeguard his/her health over the foreseeable prolonged post-cancer treatment period. To achieve this, ONCORELIEF builds on the combined knowhow of its interdisciplinary industry-driven consortium that brings together state-of-the-art technological skills, design thinking methodology and occupational psychology/health sciences.
Ámbito científico
Palabras clave
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-SC1-DTH-2019
Régimen de financiación
RIA - Research and Innovation actionCoordinador
E14 3BS London
Reino Unido
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.